SYLVONNE COX: Open Payments
NPI 1992863385 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,531 in 111 payments from 26 companies in 2025. Trend: 2023 $2,570 · 2024 $2,535 · 2025 $2,531
Food & beverage: $2,531
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $311 |
| GlaxoSmithKline, LLC. | 22 | $296 |
| AstraZeneca Pharmaceuticals LP | 11 | $241 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $213 |
| Verona Pharma, Inc. | 7 | $207 |
| Regeneron Healthcare Solutions, Inc. | 6 | $184 |
| Grifols USA, LLC | 8 | $182 |
| Amgen Inc. | 5 | $105 |
| Insmed, Inc. | 3 | $92 |
| Axsome Therapeutics, Inc. | 3 | $73 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, Ohtuvayre, Prolastin-C Liquid, OFEV, Arikayce, Sunosi.
Industry payments across GA — which companies pay providers there.
